BCIQ Profiles

Company Profile Report

Pfizer, BioNTech on track to make hundreds of millions of COVID-19 vaccine doses this year

Plus Vaxart’s vaccine selected for Warp Speed preclinical testing, and trio of vaccine manufacturing deals

Pfizer and its partner BioNTech could obtain emergency use authorization for a COVID-19 vaccine as early as October, and expect to be able to produce hundreds of millions of doses in 2020 and a billion doses in 2021, Albert Bourla, chairman and CEO of Pfizer, said Friday.

Pfizer’s news came the same day that Vaxart

Read the full 551 word article

How to gain access

Continue reading with a
two-week free trial.